Metabolic and nonmetabolic components of fatigue monitored with 31P-NMR

Phosphate increase during fatigue affects crossbridge kinetics in intact mouse muscle at physiological temperature

KEY POINTS

Actomyosin ATP hydrolysis occurring during muscle contraction releases inorganic phosphate [P_i ] in the myoplasm. High [P_i ] reduces force and affects force kinetics in skinned muscle fibres at low temperature. These effects decrease at high temperature, raising the question of their importance under physiological conditions. This study provides the first analysis of the effects of P_i on muscle performance in intact mammalian fibres at physiological temperature. Myoplasmic [P_i ] was raised by fatiguing the fibres with a series of tetanic contractions. [P_i ] increase reduces muscular force mainly by decreasing the force of the single molecular motor, the crossbridge, and alters the crossbridge response to fast length perturbation indicating faster kinetics. These results are in agreement with schemes of actomyosin ATPase and the crossbridge cycle including a low- or no-force state and show that fibre length changes perturb the P_i -sensitive force generation of the crossbridge cycle.

ABSTRACT

Actomyosin ATP hydrolysis during muscle contraction releases inorganic phosphate, increasing [P_i ] in the myoplasm. Experiments in skinned fibres at low temperature (10-12°C) have shown that [P_i ] increase depresses isometric force and alters the kinetics of actomyosin interaction. However, the effects of P_i decrease with temperature and this raises the question of the role of P_i under physiological conditions. The present experiments were performed to investigate this point. Intact fibre bundles isolated from the flexor digitorum brevis of C57BL/6 mice were stimulated with a series of tetanic contractions at 1.5 s intervals at 33°C. As show previously the most significant change induced by a bout of contractile activity similar to the initial 10 tetani of the series was an increase of [P_i ] without significant Ca²⁺ or pH changes. Measurements of force, stiffness and responses to fast stretches and releases were therefore made on the 10th tetanus of the series and compared with control. We found that (i) tetanic force at the 10th tetanus was ∼20% smaller than control without a significant decrease of crossbridge stiffness; and (ii) the force recovery following quick stretches and releases was faster than in control. These results indicate that at physiological temperature the increase of [P_i ] occurring during early fatigue reduces tetanic force mainly by depressing the individual crossbridge force and accelerating crossbridge kinetics.

Long-chain n-3 DHA reduces the extent of skeletal muscle fatigue in the rat in vivo hindlimb model

Dietary fish oil modifies skeletal muscle membrane fatty acid composition and oxygen efficiency similar to changes in the myocardium. Oxygen efficiency is a key determinant of sustained force in mammalian skeletal muscle. Therefore, in the present study, we tested the effects of a fish-oil diet on skeletal muscle fatigue under the stress of contraction using the rat in vivo autologous perfused hindlimb model. For 8 weeks, male Wistar rats were fed a diet rich in saturated fat (SF), a diet rich in n-6 PUFA or a diet rich in long-chain (LC) n-3 PUFA DHA derived from fish oil. In anaesthetised, mechanically ventilated rats, with their hindlimbs perfused with arterial blood at a constant flow, the gastrocnemius–plantaris–soleus muscle bundle was stimulated via sciatic nerve (2 Hz, 6–12 V, 0·05 ms) to contract repetitively for 30 min. Rats fed the n-3 PUFA diet developed higher maximum twitch tension than those fed the SF and n-6 PUFA diets (P< 0·05) and sustained twitch tension through more repetitions before the tension declined to 50 % of the maximum twitch tension (P< 0·05). The n-3 PUFA group used less oxygen for tension developed and produced higher venous lactate concentrations with no difference in glycogen utilisation compared with the SF and n-6 PUFA groups. These results further support that incorporation of DHA into skeletal muscle membranes increases the efficiency of oxygen use over a range of contractile force and this is expressed as a higher sustained force and prolonged time to fatigue.

A peripheral governor regulates muscle contraction

Active skeletal muscles are capable of keeping the global [adenosine triphosphate (ATP)] reasonably constant during exercise, whether it is mild exercise, activating a few motor units, or all-out exercise using a substantial mass of muscle. This could only be accomplished if there were regulatory processes in place not only to replenish ATP as quickly as possible, but also to modulate the rate of ATP use when that rate threatens to exceed the rate of ATP replenishment, a situation that could lead to metabolic catastrophe. This paper proposes that there is a regulatory process or "peripheral governor" that can modulate activation of muscle to avoid metabolic catastrophe. A peripheral governor, working at the cellular level, should be able to reduce the cellular rate of ATP hydrolysis associated with muscle contraction by attenuating activation. This would necessarily cause something we call peripheral fatigue (i.e., reduced contractile response to a given stimulation). There is no doubt that peripheral fatigue occurs. It has been demonstrated in isolated muscles, in muscles in situ with no central nervous system input, and in intact human subjects performing voluntary exercise with small muscle groups or doing whole-body exercise. The regulation of muscle activation is achieved in at least 3 ways (decreasing membrane excitability, inhibiting Ca2+ release through ryanodine receptors, and decreasing the availability of Ca2+ in the sarcoplasmic reticulum), making this a highly redundant control system. The peripheral governor attenuates cellular activation to reduce the metabolic demand, thereby preserving ATP and the integrity of the cell.

Skeletal Muscle Fatigue: Cellular Mechanisms

Repeated, intense use of muscles leads to a decline in performance known as muscle fatigue. Many muscle properties change during fatigue including the action potential, extracellular and intracellular ions, and many intracellular metabolites. A range of mechanisms have been identified that contribute to the decline of performance. The traditional explanation, accumulation of intracellular lactate and hydrogen ions causing impaired function of the contractile proteins, is probably of limited importance in mammals. Alternative explanations that will be considered are the effects of ionic changes on the action potential, failure of SR Ca2+release by various mechanisms, and the effects of reactive oxygen species. Many different activities lead to fatigue, and an important challenge is to identify the various mechanisms that contribute under different circumstances. Most of the mechanistic studies of fatigue are on isolated animal tissues, and another major challenge is to use the knowledge generated in these studies to identify the mechanisms of fatigue in intact animals and particularly in human diseases.

New experimental setup for studying strictly noninvasively skeletal muscle function in rat using 1H-magnetic resonance (MR) imaging and 31P-MR spectroscopy

Traditional setups for in situ MR investigation of skeletal muscle function in animals use invasive systems for muscle stimulation and force measurement. These systems require surgical preparation and therefore exclude repetitive investigations on the same animal. This article describes a new experimental setup allowing strictly noninvasive MR investigations of muscle function in contracting rat gastrocnemius muscle using 1H-MR imaging and 31P-MR spectroscopy. The novelty of this setup is the integration of two noninvasive systems allowing muscle contraction by transcutaneous stimulation and force measurement with a dedicated ergometer. Muscle function was investigated in 20 rats (275-300 g) through a fatiguing stimulation protocol, either with this noninvasive setup (n = 10) or with a traditional MR setup (n = 10). T2-weighted images demonstrated that transcutaneous stimulation activated mainly the gastrocnemius muscle. Moreover, the changes in force development and in energy metabolism obtained with the noninvasive setup were qualitatively and quantitatively similar to those obtained with the traditional setup. This noninvasive setup is thus suitable for investigating skeletal muscle function in situ. It offers the possibility to repeat investigations in the same animal, avoiding individual variability and enabling longitudinal follow-up studies. This opens up new perspectives in various research areas including pharmaceutical research.

In vivo MR investigation of skeletal muscle function in small animals

In vivo 31P-MRS investigations have been widely used in small animals to study skeletal muscle function under normal and pathological conditions. Paradoxically in these studies, the benefit provided by 31P-MRS in terms of non-invasiveness is lost because of the utilization of experimental setups that integrate invasive devices for inducing muscle contractions and for measuring mechanical performance. These traditional methodologies, which require surgical preparations, have obvious limitations regarding repeatability in the same animal. The purpose of this review is to highlight the technical aspects of the in vivo MR investigations of skeletal muscle function in small animal models. We will more particularly address the issue related to the invasiveness of different procedures used so far in order to show finally that a further step into non-invasiveness can be achieved, in particular with the support of muscle functional 1H-MRI.

Phosphate metabolites in muscular contraction caused by magnetic stimulation

The metabolism of high energy phosphates during muscular contraction due to direct electrical stimulation, indirect stimulation via nerve excitation, and magnetic stimulation was studied in isolated muscles (frog sartorius muscles) by (31)P nuclear magnetic resonance ((31)P-NMR). Twitch amplitudes elicited by each stimulus were measured alternatively at 3 mm displacement loading and 5 g weight. Both the creatine/inorganic phosphate (PCr/Pi) and pH changes were more marked in direct electrical stimulation than in magnetic stimulation. The muscular contraction caused by magnetic stimulation showed less fatigue than that caused by direct electrical muscular stimulation.

Muscle contractile properties during intermittent nontetanic stimulation in rat skeletal muscle

To examine changes in contractile properties and mechanisms of fatigue during submaximal nontetanic skeletal muscle activity, in situ perfused soleus (60-min protocol) and extensor digitorum longus (EDL; 10-min protocol) muscles of the rat were electrically stimulated intermittently at low frequency. The partly fused trains of contractions showed a two-phase change in appearance. During the first phase, relaxation slowed, one-half relaxation time increased, and maximal relaxation first derivative of force (dF/dt) decreased. Developed force during the trains was reduced and was closely related to the rate of relaxation in this first phase. During the second phase, relaxation became faster again, one-half relaxation time decreased, and force returned to resting levels between contractions in a train. In contrast, developed force remained reduced, so that peak force of the contractions was 51% (soleus) and 30% (EDL) of control. In the soleus muscle, the changes in contractile properties were not related to ATP, creatine phosphate, or lactate content. The changes in contractile properties fit best with a mechanism of fatigue involving changes in Ca(2+) handling by the sarcoplasmic reticulum.

Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis

Motor fatigue is a common complaint in patients with amyotrophic lateral sclerosis (ALS), but is often excluded, unlike weakness, from the clinical assessment of these patients. This could be due to the complexity and often painful assessment techniques of this motor deficit. This study examines the feasibility of quantitative assessment of motor fatigue by modifying presently available force measurements. The relationship between weakness and fatigue in ALS patients was also examined. Fifty-four ALS patients and 39 normal control subjects performed 30 s of sustained maximal voluntary isometric contraction (MVIC) of elbow flexors (EF), knee extensors (NE), and ankle dorsiflexors (DF), using a computerized force measurement system and standardized testing procedures. Fatigue index (FI) was digitally calculated, from the force-time curve, as the percentage of MVIC unable to be sustained over the 30-s period. Fatigue was greater in ALS patients than in normal control (mean=23% vs. 15%) in all muscles including muscles that were not clearly weak. Weakness and fatigue were poorly correlated in ALS patients and may be independent measures of the pathogeneses of ALS.

Effect of resistance training on muscle fatigue and recovery in intact rats

PURPOSE

To examine the effect of resistance training on muscle fatigue from intermittent contractions and subsequent recovery in intact rats.

METHODS

By using electrical stimulation, plantar flexor muscles were trained with eccentric and concentric contractions (5 x 10 repetitions, 5 d x wk(-1) for 6 wk) during ankle rotations. By using nerve stimulation, concentric contractions (40) imposed on isometric contractions (stimulation time, 1.9 s; rest period, 13.6 s; intermittent contractions) induced fatigue. During recovery, equivalent contractions were used every 5 min for 30 min.

RESULTS

Training increased isometric forces (19% and 23% at ankle positions of 1.57 and 0.70 rad), but muscle weights were not changed. After training, smaller declines in isometric (control, 68.9+/-1.4%; trained, 58.8+/-2.9%) and average concentric force (control, 71.6+/-0.7%; trained, 65.5+/-2.8%) occurred from fatigue. Recovery for 5 min returned isometric and average concentric force to 61.7+/-2.2% and 65.1+/-2.5% of initial values for controls and 76.9+/-2.2% and 77.1+/-2.2% after training. After recovery for 30 min, these forces were 87.6+/-0.7% and 89.2+/-1.1% of initial values for controls and recovered almost completely (94.2+/-1.3% and 94.6+/-1.6%) in trained muscles. During fatigue, the decline in force during successive concentric contractions was larger after training (from 19.7+/-1.1% to 50.1+/-2.0%; controls, from 19.9+/-2.0% to 41.7+/-1.4%). Recovery of this decline in force was training-independent and complete within 5 min.

CONCLUSIONS

Rat plantar flexor muscles adapt to 6 wk of 5 d x wk(-1) resistance training with: 1) increased isometric force, 2) smaller losses in isometric and average concentric force during fatigue, 3) larger force decline during concentric contractions during fatigue, and 4) improved recovery following fatigue. Different mechanisms might account for the recovery of the average concentric force and the decline in force during concentric contractions.

Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia

BACKGROUND

Administration of angiogenic factors stimulates neovascularization in ischemic tissues. However, there is no evidence that angiogenesis can be induced in normoperfused skeletal muscles. We tested the hypothesis that adenovirus-mediated intramuscular (IM) gene transfer of the 121-amino-acid form of vascular endothelial growth factor (AdCMV.VEGF(121)) could stimulate neovascularization in nonischemic skeletal muscle and consequently attenuate the hemodynamic deficit secondary to surgically induced ischemia.

METHODS AND RESULTS

Rabbits and rats received IM injections of AdCMV.VEGF(121), AdCMV.Null, or saline in the thigh, 4 weeks (rabbits) or 2 weeks (rats) before femoral artery removal in the injected limb. In unoperated rats, at the site of injection of AdCMV.VEGF(121), we found 96% and 29% increases in length density of arterioles and capillaries, respectively. Increased tissue perfusion (TP) to the ischemic limb in the AdCMV.VEGF(121) group was documented, as early as day 1 after surgery, by improved blood flow to the ischemic gastrocnemius muscle measured by radioactive microspheres (AdCMV.VEGF(121)=5.69+/-0.40, AdCMV.Null=2.97+/-0.50, and saline=2.78+/-0.43 mL x min(-1) x 100 g(-1), P<0.001), more angiographically recognizable collateral vessels (angioscore) (AdCMV. VEGF(121)=50.58+/-1.48, AdCMV.Null=29.08+/-4.22, saline=11.83+/-1.90, P<0.0001), and improvement of the bioenergetic reserve of the gastrocnemius muscle as assessed by (31)P NMR spectroscopy. Follow-up studies showed that superior TP to the ischemic limb in the AdCMV.VEGF(121) group persisted until it was equalized by spontaneous collateral vessel development in untreated animals.

CONCLUSIONS

IM administration of AdCMV.VEGF(121) stimulates angiogenesis in normoperfused skeletal muscles, and the newly formed vessels preserve TP after induction of ischemia.

EMG and metabolite-based prediction of force in paralyzed quadriceps muscle under interrupted stimulation

A major issue associated with functional electrical stimulation (FES) of a paralyzed limb is the decay with time of the muscle force as a result of fatigue. A possible means to reduce fatigue during FES is by using interrupted stimulation, in which fatigue and recovery occur in sequence. In this study, we present a model which enables us to evaluate the temporal force generation capacity within the electrically activated muscle during first stimulation fatigue, i.e., when the muscle is activated from unfatigued initial conditions, and during postrest stimulation, i.e., after different given rest durations. The force history of the muscle is determined by the activation as derived from actually measured electromyogram (EMG) data, and by the metabolic fatigue function expressing the temporal changes of muscle metabolites, from existing data acquired by in vivo 31P MR spectroscopy in terms of the inorganic phosphorus variables, Pi or H2PO4-, and by the intracellular pH. The model was solved for supra-maximal stimulation in isometric contractions separated by rest periods, and compared to experimentally obtained measurements. EMG data were fundamental for prediction of the ascending force during its posttetanic response. On the other hand, prediction of the decaying phase of the force was possible only by means of the metabolite-based fatigue function. The prediction capability of the model was assessed by means of the error between predicted and measured force profiles. The predicted force obtained from the model in first stimulation fatigue fits well with the experimental one. In postrest stimulation fatigue, the different metabolites provided different prediction capabilities of the force, depending on the duration of the rest period. Following rest duration of 1 min, Pi provided the best prediction of force; H2PO4- extended the prediction capacity of the model to up to 6 min and pH provided a reliable prediction for rest durations longer than 12 min. The results presented shed light on the roles of EMG and of metabolites in prediction of the force history of a paralyzed muscle under conditions where fatigue and recovery occur in sequence.